🇺🇸 Herclon in United States

39 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 28 March 2025 – 28 March 2026
• Total reports: 39

Most-reported reactions

1. Death — 10 reports (25.64%)
2. Drug Ineffective — 7 reports (17.95%)
3. Disease Progression — 4 reports (10.26%)
4. Metastases To Central Nervous System — 4 reports (10.26%)
5. Abdominal Pain Upper — 3 reports (7.69%)
6. Breast Cancer Recurrent — 3 reports (7.69%)
7. Bedridden — 2 reports (5.13%)
8. Cardiac Disorder — 2 reports (5.13%)
9. Heart Rate Decreased — 2 reports (5.13%)
10. Metastases To Bone — 2 reports (5.13%)

Source database →

Frequently asked questions

Is Herclon approved in United States?

Herclon does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Herclon in United States?

Incepta Pharmaceuticals Ltd is the originator. The local marketing authorisation holder may differ — check the official source linked above.